{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:31Z","timestamp":1786119451749,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/ppo.0b013e3181f28ab3","type":"journal-article","created":{"date-parts":[[2010,10,2]],"date-time":"2010-10-02T06:57:32Z","timestamp":1286002652000},"page":"467-472","source":"Crossref","is-referenced-by-count":12,"title":["Palliative Chemotherapy"],"prefix":"10.1097","volume":"16","author":[{"given":"Keith M.","family":"Swetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-8-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1548-5315(11)70009-2","article-title":"Providing palliative care and transitioning patients to hospice: how oncologists and palliative care specialists can work together.","volume":"7","author":"Harrington","year":"2010","journal-title":"Community Oncol"},{"key":"R3-8-20210203","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/jhm.467","article-title":"Maximal medical therapy and palliative care can work together: when are advanced care measures appropriate?","volume":"4","author":"Swetz","year":"2009","journal-title":"J Hosp Med"},{"key":"R4-8-20210203","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/bmj.38103.423576.55","article-title":"What do patients receiving palliative care for cancer and their families want to be told? A Canadian and Australian qualitative study.","volume":"328","author":"Kirk","year":"2004","journal-title":"BMJ"},{"key":"R5-8-20210203","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/bjc.1988.218","article-title":"Cancer patients' perceptions of their disease and its treatment.","volume":"58","author":"Mackillop","year":"1988","journal-title":"Br J Cancer"},{"key":"R6-8-20210203","first-page":"204","article-title":"Patients with advanced cancer: a survey of the understanding of their illness and expectations from palliative radiotherapy for symptomatic metastases.","volume":"13","author":"Chow","year":"2001","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R8-8-20210203","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1200\/JCO.2007.12.6110","article-title":"Hope and prognostic disclosure.","volume":"25","author":"Mack","year":"2007","journal-title":"J Clin Oncol"},{"key":"R9-8-20210203","first-page":"521","article-title":"Hope is maintained when patients with advanced metastatic cancer are given truthful prognostic information.","volume":"24","author":"Smith","year":"2010","journal-title":"Oncology (Williston Park)"},{"key":"R10-8-20210203","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1634\/theoncologist.2010-S1-65","article-title":"Concrete options and ideas for increasing value in oncology care: the view from one trench.","volume":"15","author":"Smith","year":"2010","journal-title":"Oncologist"},{"key":"R11-8-20210203","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1200\/JCO.2005.03.6236","article-title":"Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer.","volume":"24","author":"Matsuyama","year":"2006","journal-title":"J Clin Oncol"},{"key":"R12-8-20210203","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1200\/JCO.1996.14.2.671","article-title":"Outcomes of cancer treatment for technology assessment and cancer treatment guidelines.","volume":"14","year":"1996","journal-title":"J Clin Oncol"},{"key":"R13-8-20210203","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1200\/JCO.2009.23.1183","article-title":"American Society of Clinical Oncology guidance statement: the cost of cancer care.","volume":"27","author":"Meropol","year":"2009","journal-title":"J Clin Oncol"},{"key":"R14-8-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JOP.777002","article-title":"Understanding patient perspectives on communication about the cost of cancer care: a review of the literature.","volume":"6","author":"Hofstatter","year":"2010","journal-title":"J Oncol Pract"},{"key":"R16-8-20210203","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1377\/hlthaff.2009.0077","article-title":"Cancer therapy costs influence treatment: a national survey of oncologists.","volume":"29","author":"Neumann","year":"2010","journal-title":"Health Aff (Millwood)"},{"key":"R18-8-20210203","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1200\/JCO.2008.21.0534","article-title":"Efficacy does not necessarily translate to cost-effectiveness-a case study in the challenges associated with 21st century cancer drug pricing.","volume":"27","author":"Hiller","year":"2009","journal-title":"J Clin Oncol"},{"key":"R19-8-20210203","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/annonc\/mdp552","article-title":"Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer.","volume":"21","author":"Seruga","year":"2010","journal-title":"Ann Oncol"},{"key":"R20-8-20210203","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1200\/JCO.1995.13.9.2464","article-title":"Ethics in oncology: balancing interests of the patient, oncologist, and society.","volume":"13","author":"Smith","year":"1995","journal-title":"J Clin Oncol"},{"key":"R21-8-20210203","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1200\/JCO.2000.18.19.3441","article-title":"Tell it like it is.","volume":"18","author":"Smith","year":"2000","journal-title":"J Clin Oncol"},{"key":"R22-8-20210203","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00520-007-0372-2","article-title":"Patient-oncologist communication in advanced cancer: predictors of patient perception of prognosis.","volume":"16","author":"Robinson","year":"2008","journal-title":"Support Care Cancer"},{"key":"R24-8-20210203","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0272989X08329344","article-title":"Long-term health outcomes of a decision aid: data from a randomized trial of adjuvant! In women with localized breast cancer.","volume":"29","author":"Vickers","year":"2009","journal-title":"Med Decis Making"},{"key":"R25-8-20210203","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1200\/JCO.2009.23.5622","article-title":"American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.","volume":"27","author":"Azzoli","year":"2009","journal-title":"J Clin Oncol"},{"key":"R27-8-20210203","first-page":"2667","article-title":"The role of chemotherapy at the end of life: \"when is enough, enough?\" JAMA.","volume":"299","author":"Harrington","year":"2008","journal-title":""},{"key":"R28-8-20210203","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1200\/JCO.2008.21.6770","article-title":"Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center.","volume":"27","author":"Blayney","year":"2009","journal-title":"J Clin Oncol"},{"key":"R29-8-20210203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1200\/JCO.2009.24.6397","article-title":"Paradoxes in advance care planning.","volume":"28","author":"Dow","year":"2010","journal-title":"J Clin Oncol"},{"key":"R30-8-20210203","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/jama.300.14.1665","article-title":"Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment.","volume":"300","author":"Wright","year":"2008","journal-title":"JAMA"},{"key":"R31-8-20210203","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1089\/jpm.2007.2480","article-title":"A qualitative study of oncologists' approaches to end-of-life care.","volume":"11","author":"Jackson","year":"2008","journal-title":"J Palliat Med"},{"key":"R32-8-20210203","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/archinternmed.2008.587","article-title":"Health care costs in the last week of life: associations with end-of-life conversations.","volume":"169","author":"Zhang","year":"2009","journal-title":"Arch Intern Med"},{"key":"R33-8-20210203","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jama.283.8.1065","article-title":"Decisions to withdraw life-sustaining treatment: a moral algorithm.","volume":"283","author":"Pellegrino","year":"2000","journal-title":"JAMA"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00130404-201009000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:34:14Z","timestamp":1786041254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130404-201009000-00008"}},"subtitle":["When Is It Worth It and When Is It Not?"],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0b013e3181f28ab3","relation":{},"ISSN":["1528-9117"],"issn-type":[{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}